When: Price at $185-190 with RSI <40 washout

Then: Initiate optional third tranche at 2% sizing

When: 10Y breaks above current high and stays >1 week OR Fed speaker previews October hike

Then: PAUSE tier-entry process even at lower prices

HOLD with a defined buy zone at $188-$195 and invalidation at $185; wait for pullback rather than chase current levels

• A 15.8% single-day move represents a 99th-percentile event that typically resolves with mean reversion, not sustained upside continuation
• RSI at 70 and price above upper Bollinger Band indicate stretched momentum; the stock can roll over hard from overbought levels
• Macro backdrop remains hawkish: 10Y at multi-decade highs, Fed in hawkish hold, 26% priced probability of rate hike at October meeting, 8% recession odds
• Forward P/E of 14.5x is based on consensus estimates revised upward today; risk of compression to 13-14x as estimates normalize over the next quarter
• Consolidation at elevated levels without being positioned is a non-event for capital not deployed, not a missed opportunity
• Position sizing should cap new entrants at 3-4% to allow participation while protecting against realistic 10-20% drawdown scenarios
• Sector rotation (IBM, Infosys, EPAM) cuts both ways; sympathy moves up become sympathy moves down (2022 example)
• Realistic downside scenarios: 10% pullback to 200 SMA, 15% pullback to lower Bollinger Band, 20% drawdown if macro turns
• The 3-4% cap is professional portfolio construction, not timidity—it allows managing through sector reversals
• Patience is a position; capital preservation is a strategy after a 99th-percentile move in a hawkish macro environment

→ vs aggressive: Mean reversion to $188-$195 is a non-event for undeployed capital, not a loss; the aggressive view treats the absence of a pullback as a missed opportunity when it is simply a condition not met

→ vs aggressive: The RSI 65-85 for weeks scenario picks the bull case from a distribution of outcomes and presents it as base case; a rollover from 70 is equally plausible and historically common after 99th-percentile moves

→ vs aggressive: Macro dismissal is dangerous: today's price action in spite of yields tells us nothing about what happens next if hawkish data prints arrive; conflating 'moved up despite macro' with 'macro doesn't matter' is a fundamental misunderstanding of risk management

→ vs aggressive: The 12.5% worst-case framing obscures realistic scenarios: 10-20% drawdowns are plausible from here and represent meaningful portfolio damage at full position size

→ vs aggressive: Forward P/E of 14.5x anchors on post-beat consensus that tends to overshoot; multiple could compress to 13-14x as estimates normalize and macro pressure reasserts

→ vs aggressive: Sector rotation cuts both ways; adding full exposure to a cohort that moved together on momentum leaves one vulnerable to coordinated unwinds (2022 precedent)

HOLD existing position; deploy new capital via three-tiered plan at $200-205, $193-195, and optional $185-190 on RSI below 40, sized at 2% per tranche (4-6% total max add)

• Record bookings and raised FY27 guide confirm structural thesis; existing position should be held
• Three-tier entry plan: $200-205 (breakout retest), $193-195 (200 SMA retest), optional $185-190 on RSI below 40
• Each tier sized at 2% per tranche, maximum 4-6% total addable new capital
• Combined portfolio weight target: 6-9% range depending on which tiers trigger
• Trailing stop at tighter of 10 EMA ($186.64) or 200 SMA ($193.81) on new entries
• Hard invalidation level at $185; realistic stop-triggered drawdown is 12-15% clean or 15-20% if gapped through
• Gap-down risk to $190 is realistic adverse scenario after 15.8% up day
• Macro constraint: pause new adds if 10Y breaks above today's high and holds, or Fed previews October hike
• Evaluate on 1-3 month basis ahead of Q1 FY27 print; look for higher low structure above $200
• Data anomaly with phantom gap in mid-2026 argues for tighter sizing, not looser
• Conservative analyst ignores opportunity cost of waiting for $188 if stock grinds to $240
• Conservative analyst's mean reversion to $188 may not match actual structure of sector re-rating
• Conservative analyst should consider trimming 10-20% of existing position to lock gains symmetrically
• Management-issued FY27 guide anchors forward P/E; less risk of compression than typical post-print normalization

→ vs aggressive: No block trade data, 13F filings, or options flow evidence for institutional accumulation narrative; 15.8% up day on volume is equally consistent with short covering, systematic rebalancing, or ETF creation flow

→ vs aggressive: Macro dismissal is a time-frame error: single session price action doesn't constrain what matters to marginal buyer over next 2-4 weeks; Fed has 26% priced October hike probability and 10Y just had biggest monthly gain since 2022

→ vs aggressive: $185 hard stop underestimates realistic drawdown: gaps through stops on open can create 15-20% realized loss, not 12.5%

→ vs aggressive: Full position sizing with 12-15% realistic downside in elevated short-term vol environment underestimates portfolio damage if wrong

→ vs conservative: Opportunity cost is real: waiting months for $188 while stock grinds to $240 sacrifices compounding; 'zero-cost option' framing is incorrect

→ vs conservative: 99th-percentile mean reversion in thin-catalyst days doesn't apply to record bookings thesis-break print; reversion likely to $200-203 breakout retest, not deep $188-193 dive

→ vs conservative: 200 SMA just flipped from resistance to support; retesting it as new support is more likely consolidation pattern than diving through it

→ vs conservative: Forward P/E anchored to management-issued FY27 guide, not sell-side drift; estimates may not normalize downward like typical post-print compression scenario

→ vs conservative: Cap on new adds at 3-4% without considering trimming 10-20% of existing position is asymmetric; symmetric risk plan should lock in some gains from the day